
Doctor Stories
Stanford Medicine Interventional Cardiologist Honored for International Influence in Science and Education
11.17.2022
Stanford Health Care’s legacy as a health care leader is a direct result of the skill and dedication of its clinicians, researchers, and scientists. Through his leadership in innovation, research, and international outreach, interventional cardiologist Alan C. Yeung, MD, has made significant contributions to this legacy.
Dr. Yeung is medical director of cardiovascular health, senior medical director of International Medical Services, and past chief of the Division of Cardiovascular Medicine at Stanford. Over the past 30 years, Yeung has advanced the field of interventional cardiology, both in the U.S. and the Asia-Pacific region.
2022 TCTAP Master of the Masters Award Recipient
Dr. Yeung is a distinguished leader in science, academic medicine, and clinical care. In recognition of his significant achievements and contributions, Dr. Yeung recently received the 2022 Master of the Masters Award from Transcatheter Cardiovascular Therapeutics Asia Pacific (TCTAP). For decades, Dr. Yeung has been a TCTAP moderator, panelist, and lecturer, inspiring and educating fellow scientists and physicians in the field of interventional cardiology.
CARE AT STANFORD

Our innovative catheter procedures can determine the cause of your chest pain and treat problems like heart attacks without surgery.
650-725-2621
Dr. Yeung’s commitment to bridging interventional cardiology from the U.S. to the Asia-Pacific region began early in his career. In 1994, Dr. Yeung organized the first Stanford Asia Cardiovascular Symposium in his hometown of Hong Kong.
In the years since, Dr. Yeung has traveled to Asia more than 160 times, sharing knowledge and changing the landscape of interventional cardiology across the globe. Yeung has led numerous bilateral exchanges, fellows training events, and open discussions on the fundamentals of interventional cardiology in numerous hospitals across the Asia-Pacific region.
Renowned Researcher and Educator
Throughout his career, Dr. Yeung has published more than 300 papers in top-tier journals, covering a wide range of interventional cardiology topics. From percutaneous coronary artery intervention to transcatheter aortic valve replacement, Dr. Yeung has been on the leading edge of interventional cardiology breakthroughs as a researcher and scientist.
Dr. Yeung’s early research was focused on the coronary physiology of endothelial dysfunction and intimal thickening, a result of his study under Peter Ganz, MD, of Harvard Medical School/Brigham and Women’s Hospital (now at University of California, San Francisco). His recent work with William Fearon, MD, has led to physiological studies in the coronary arteries using fractional flow reserve (FFR) and index of microcirculatory resistance (IMR). Most recently, this line of research led to the FAME 3 trial that compared the results of FFR-guided percutaneous coronary intervention (PCI) to coronary artery bypass graft (CABG).
As a prominent educator, Dr. Yeung is also playing an integral role in training the next generation of interventional cardiologists. He has served as chairman of the American Board of Internal Medicine Interventional Board Committee as well as writing textbooks for fellows in training and practicing interventionalists.
“I look forward to the years ahead as we continue to forge paths through more research and discoveries in interventional cardiology,” said Dr. Yeung. “I’m honored to work alongside so many talented physicians and researchers who share a passion for healing through science.”
Alan Yeung, MD
Skilled, Compassionate Clinician
Dr. Yeung’s contributions to medicine extend beyond his presence in research and education. He’s also a dedicated clinician at Stanford Health Care’s renowned interventional cardiology program. Dr. Yeung treats patients with coronary artery disease and valvular heart disease.
Although Dr. Yeung is always moving forward with the latest advances in treatment, his focus remains on the patient as an individual. Dr. Yeung and the interventional cardiology team work to deliver the safest and most effective therapies so patients have the best possible outcomes.
“Exceptional patient care is at the root of everything we do as interventional cardiologists,” said Dr. Yeung. “Our commitment to research and education leads back to the bedside. Research results in better ways to treat cardiovascular conditions, and education shapes the knowledge of the next generation of physicians.”
Stanford Health Care continues to be recognized as a top-ranked cardiology hospital for its high volumes, excellent outcomes, innovations, and expertise. Stanford Health Care is ranked among the nation's top 10 Cardiology & Heart Surgery programs.5
Watch Dr. Yeung’s acceptance of the 2022 TCTAP Master of the Masters Award and learn more about interventional cardiology care at Stanford Health Care.
References:
- Doximity. Alan Ching-Yuen Yeung, MD. Accessed 6/3/2022.
- Society for Cardiovascular Angiography & Interventions. Alan Yeung, MD, FSCAI. Accessed 6/3/2022.
- Stanford Profiles. Alan Yeung, MD. Accessed 6/3/2022.
- TCTAP Daily News. Evolution of Asia-Pacific Interventional Cardiology. Accessed 6/3/2022.
- U.S. News & World Report. Best Hospitals for Cardiology & Heart Surgery. Accessed 6/3/2022.